215 related articles for article (PubMed ID: 21479684)
21. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.
Leboulleux S; Travagli JP; Caillou B; Laplanche A; Bidart JM; Schlumberger M; Baudin E
Cancer; 2002 Jan; 94(1):44-50. PubMed ID: 11815959
[TBL] [Abstract][Full Text] [Related]
22. Can intraoperative frozen section influence the extension of central neck dissection in cN0 papillary thyroid carcinoma?
Raffaelli M; De Crea C; Sessa L; Giustacchini P; Bellantone R; Lombardi CP
Langenbecks Arch Surg; 2013 Mar; 398(3):383-8. PubMed ID: 23207498
[TBL] [Abstract][Full Text] [Related]
23. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
24. The extent of surgery for thyroid medullary cancer.
Pelizzo MR; Bernante P; Piotto A; Toniato A; Girelli ME; Busnardo B; Rupolo M; Fassina A; Pennelli N
Tumori; 1994 Dec; 80(6):427-32. PubMed ID: 7900231
[TBL] [Abstract][Full Text] [Related]
25. Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study.
Twito O; Grozinsky-Glasberg S; Levy S; Bachar G; Gross DJ; Benbassat C; Rozental A; Hirsch D
Eur J Endocrinol; 2019 Jul; 181(1):13-21. PubMed ID: 31048559
[TBL] [Abstract][Full Text] [Related]
26. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
27. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.
Yen TW; Shapiro SE; Gagel RF; Sherman SI; Lee JE; Evans DB
Surgery; 2003 Dec; 134(6):890-9; discussion 899-901. PubMed ID: 14668720
[TBL] [Abstract][Full Text] [Related]
28. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
Ebina A; Sugitani I; Fujimoto Y; Yamada K
Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
[TBL] [Abstract][Full Text] [Related]
29. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
30. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
Torresan F; Cavedon E; Mian C; Iacobone M
World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
[TBL] [Abstract][Full Text] [Related]
32. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
33. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
[TBL] [Abstract][Full Text] [Related]
34. Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.
Peixoto Callejo I; Américo Brito J; Zagalo CM; Rosa Santos J
Clin Transl Oncol; 2006 Jun; 8(6):435-43. PubMed ID: 16790397
[TBL] [Abstract][Full Text] [Related]
35. Medullary thyroid carcinoma in Northern Ireland, 1967-1997.
Dolan SJ; Russell CF
Ann R Coll Surg Engl; 2000 May; 82(3):156-61. PubMed ID: 10858675
[TBL] [Abstract][Full Text] [Related]
36. Selective lateral compartment neck dissection for thyroid cancer.
Welch K; McHenry CR
J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
[TBL] [Abstract][Full Text] [Related]
37. Recognizing Persistent Disease in Well-Differentiated Thyroid Cancer and Association with Lymph Node Yield and Ratio.
Noel JE; Orloff LA
Otolaryngol Head Neck Surg; 2020 Jan; 162(1):50-55. PubMed ID: 31661359
[TBL] [Abstract][Full Text] [Related]
38. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
[TBL] [Abstract][Full Text] [Related]
39. Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer.
Greenblatt DY; Elson D; Mack E; Chen H
Asian J Surg; 2007 Apr; 30(2):108-12. PubMed ID: 17475579
[TBL] [Abstract][Full Text] [Related]
40. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
